Abstract Available data associate lipids concentrations in men with body mass index, anabolic steroids, age, and certain cytokines. Data were less clear in women, especially across the full adult lifespan, and when segmented by premenopausal and postmenopausal status. Subjects: 120 healthy women (60 premenopausal and 60 postmenopausal) in Olmsted County, MN, USA, a stable well studied clinical population. Dependent variables: measurements of 10 h fasting high-density lipoprotein cholesterol, total cholesterol, low-density lipoprotein cholesterol, and triglycerides. Independent variables: testosterone, estrone, estradiol, 5-alpha-dihydrotestosterone, and sex-hormone binding globulin (by mass spectrometry); insulin, glucose, and albumin; abdominal visceral, subcutaneous, and total abdominal fat [abdominal visceral fat, subcutaneous fat, total abdominal fat by computerized tomography scan]; and a panel of cytokines (by enzyme-linked immunosorbent assay). Multivariate forward-selection linear-regression analysis was applied constrained to P < 0.01. Lifetime data: High-density lipoprotein cholesterol was correlated jointly with age (P < 0.0001, positively), abdominal visceral fat (P < 0.0001, negatively), and interleukin-6 (0.0063, negatively), together explaining 28.1 % of its variance (P = 2.3 × 10
, 38.9 % of variance). Non high-density lipoprotein cholesterol and low-density lipoprotein cholesterol correlated positively with both total abdominal fat and interleukin-8 (P = 2.0 × 10
, 16.9 % of variance; and P = 0.0031, 9.4 % of variance, respectively). Premenopausal vs. postmenopausal comparisons identified specific relationships that were stronger in premenopausal than postmenopausal individuals, and vice versa. Age was a stronger correlate of low-density lipoprotein cholesterol; interleukin-6 of triglycerides and highdensity lipoprotein; and both sex-hormone binding globulin and total abdominal fat of non high-density lipoprotein cholesterol in premenopausal than postmenopausal women. Conversely, sex-hormone binding globulin, abdominal visceral fat, interleukin-8, adiponectin were stronger correlates of triglycerides; abdominal visceral fat, and testosterone of high-density lipoprotein cholesterol; and age of both non high-density lipoprotein and low-density lipoprotein in postmenopausal than premenopausal women. Our data delineate correlations of total abdominal fat and interleukin-8 (both positively) with non high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in healthy women across the full age range of 21-79 years along with even more specific associations in premenopausal and postmenopausal individuals. Whether some of these outcomes reflect causal relationships would require longitudinal and interventional or genetic studies. 
Introduction
Available data indicate that serum lipid concentrations vary by age, sex, ethnicity, race, comorbidities, exercise habits, adipose tissue mass, and topography, medication exposure, anti-inflammatory and proinflammatory cytokines, diet and sex-steroid levels [1, 2] , at least in men. Very limited data in comparing men and women have suggested differences by sex, putatively attributable to disparate sex-steroid milieus [3] [4] [5] [6] , and non-high-density lipoprotein cholesterol [nonHDL-C]) in women either across the full adult lifespan or in pre-vs. postmenopausal individuals studied identically. Moreover, no investigations to date have employed the criterion-based methods, mass spectrometry, to quantify both sex hormones and SHBG, which is now recognized as crucial for validity, reliability, precision, specificity, and sensitivity of sex-steroid measurements [7] . In prior studies by other study groups, specific adipocytokines associated with systemic inflammation (interleukins, TNFα) and/or insulin resistance (adiponectin) have in fact been linked to lipids in polycystic ovary syndrome, pregnancy, African women, and women with rheumatoid arthritis [8] [9] [10] [11] ). These independent variables are also sparsely analyzed together in healthy women, whether pre-or postmenopausal, or viewed together over the adult lifespan. The present study tests the thesis that, in women, CT-estimated visceral and/or subcutaneous abdominal fat, criterion-based sex-steroid, and SHBG measures, and proinflammatory cytokines correlate with major lipid moieties, including those associated in epidemiologic investigations with atherosclerotic cardiovascular events in both men and women [12, 13] .
Methods Subjects
The sample of 120 healthy women (60 pre-and 60 postmenopausal) within the allowable age range of 21-79 years studied here was described recently [14] following a paper introducing the methods of mass spectroscopy of SHBG and male sex-steroids [15] . Health was defined by exclusionary laboratory tests of renal, hematologic, metabolic, endocrine, and hepatic function in volunteers who lived independently in the Olmsted County region of Mayo Clinic, Rochester, MN, USA. Healthy women underwent a medical history and examination to exclude organ-system disease after providing written informed consent approved by Institutional Review Board. In particular, no subjects were receiving thiazides, beta-blockers, sex hormones, isoretinoin, statins, glucocorticoids, fibrates, niacin, omega-3 supplements, bile-acid resins, other hypolipidemic drugs, or dietary or exercise treatments. Serum lipid measurements were made after 10 h overnight fast.
Abdominal CT scans
Intra AVF and abdominal SCF were estimated by singleslice abdominal CT scan at L3-L4, exactly as reported [16] . The sum of AVF and SCF cross-sectional areas was taken as TAF.
Total cholesterol (TC)
Lipids were quantified in the Mayo Research Laboratories (MRL). TC was determined on the COBAS c311 (Roche Diagnostics) in EDTA plasma by absorbance spectrophotometry at 520 nm. The analytical measurement range is 4-500 mg/dL, where 1 mmol/L = 38.5 mg/dL.
HDL cholesterol (HDL-C)
The cholesterol concentration of HDL was determined by the MRL on the COBAS c311 in EDTA plasma by absorbance spectrophotometry at 610 nm. The analytical measurement range is 3-120 mg/dL, wherein 1 mmol/L = 38.7 mg/dL.
Triglycerides (TG)
TG concentrations were determined in the MRL on the COBAS c311 in EDTA plasma by absorbance spectrophotometry at 520 nm. The analytical measurement range is 9-885 mg/dL, where 1 mmol/L = 88.5 mg/dL.
NonHDL-C was the algebraic difference between TC and HDL-C. LDL-C was calculated by the Friedewald equation [17] .
Assays
The methods for all other assays were reported earlier in the primary methodology papers in men and women [14, 15] . These include mass spectrometry of testosterone, estrone, estradiol, and SHBG, and immunological assay for IL-6, IL-8, insulin, and adiponectin, as reported in women [14] .
Statistics
Stepwise forward-selection multivariate, and simple univariate, linear-regression analyses were performed using the Matlab Statistical program (MathWorks, Natick, MA). Selection of independent variables was done a priori based upon extensive literature search in both men and women, identifying suspected, proven (true positive) and disproven (true negative) factors potentially relatable to the dependent variables, TG, LDL, HDL, and nonHDL (Introduction). The independent variables explored were age, BMI, (total) testosterone, estrone, estradiol, SHBG, albumin, glucose, insulin, AVF, TAF (and their difference, SCF), IL-6, IL-8, and adiponectin. Analysis of variance was used for trend analysis across the three fat compartments, subcutaneous, visceral, and total abdominal adiposity. To allow for multiple comparisons, P < 0.01 was construed as statistically significant, resulting in only one false-positive significance per 100 comparisons, as suggested by O'Brien [18] . R denotes the calculated parametric Pearson correlation coefficient, and its square the classical coefficient of determination to estimate the fractional variance explained by the association [19] .
Results
The baseline epidemiological data, serving as independent variables, for this cohort of 120 women were presented previously [14] , and are reproduced as mean ± SEM, median (range) Table 1. In brief, over the full lifetime (N = 120), independent variables had absolute ranges as follows: age 21-79 years, BMI 19-47 kg/m 2 , glucose 74-118 mg/dL allowing for impaired glycemia but not DM-II (glucose ≥ 126 mg/dL), insulin 1-14 µU/mL, estrone 12-57 pg/ml, estradiol 3-67 pg/mL, AVF 7.1-297 cm 2 , total abdominal fat 53-883 cm 2 , SCF 46-587 cm 2 , mass spectrometry SHBG 13-363 nmol/L, testosterone (T) 8-73 ng/dL, along with normal IL-6, IL-8, and adiponectin. The dependent variables were the three directly measured and two derived lipid moieties, which had median (and range) values as follows (mg/dL): TC 190 (114-297), TG 90 (39-232), HDL-C 55 (26-99), nonHDL-C 165 (63-236) and LDL-C 118 (54-199). Table 1 adds the mean ± SEM. Table 2 segments the overall lifetime data by giving the corresponding mean, SEM, and median data for pre-(N = 60) and postmenopausal (N = 60) women separately. As expected, the following measures differed by category of menopause at P ≤ 0.01: age, BMI, T, E 1 , E 2 , AVF, TAF, TC, nonHDL, and LDL. In contrast, insulin, glucose, HDL, and albumin did not differ in the two groups.
The main statistical estimate of interest was the parametric (Pearson's) correlation coefficient for the putative relationship between the CT-defined fat compartments (AVF, TAF, SCF, independent variables) and the five main lipid categories (dependent variables) in the group of all 120 women, and separately in pre-and postmenopausal subgroups. The main dependent variable, TC, showed non significant associative trends (0.01 < P < 0.05) with the independent variables SCF, TAF, AVF, with the largest absolute trend being positive for TAF (P = 0.017) (row 1, Table 3 ). The dependent variable, TG, correlated significantly and positively with each of SCF, TAF, and AVF (all P < 10 −4 ) (row 2, Table 3 ), denoting very strong statistical effects. Multivariate stepwise forward-selection regression showed that the independent variable AVF accounted statistically for most of the positive effects of TAF and SCF on TG (multivariate adjusted R 2 = 0.280, P = 0.0005).
For HDL-C in all 120 women as the dependent variable, (row 3, Table 3 ), each of SCF, TAF, and AVF was a significant univariate (negative) correlate (0.0005 ≤ P ≤ 0.0054). SCF per se showed the greater association with HDL-C at multivariate adjusted R 2 = 0.063 and P = 0.0054. The simple linear relationship for this correlation is depicted in Fig. 1 (top) .
Further linear regression analysis in all 120 women showed that both dependent variables, nonHDL-C, and LDL-C, were strongly correlated with each of the independent variables SCF, TAF, and AVF (0.0001 ≤ P ≤ 0.0093) Table 3 (rows 4 and 5). For nonHDL-C, multivariate stepwise forward-selection analysis indicated that these effects were together explained by the single independent variable, AVF (multivariate adjusted R 2 = 0.112, P = 0.0093). For LDL-C, multivariate analysis showed that its correlations were mainly explained by SCF (multivariate adjusted R 2 = 0.056, P = 0.0093). The relationship was well approximated by simple linear regression: Fig. 1 (bottom) .
Further regression analysis evaluated the statistical correlations of lipid moieties with a priori demographic (independent) variables (Methods). For TC (dependent variable), only age (independent) showed significant univariate positive association (P = 0.0071). This remained highly significant after stepwise multivariate adjustment, yielding R 2 = 0.093 and P = 6.9 × 10 −4 .
TG as a dependent variable was correlated positively at P < 0.01 with univariate independent variables, BMI, insulin, AVF, TAF, SCF, and IL-6 (all 10 −4 < P ≤ 0.0028).
TG's association with glucose per se was non significant P = 0.013. By stepwise multivariate regression, TG correlated jointly with all three of SHBG, AVF, and IL-6 (multivariate adjusted R 2 = 0.389, P = 1.6 × 10 −12 ), with the single strongest correlation attributable to AVF at P < 10 −4 . Data are N = 60 pre-and N = 60 postmenopausal women. P < 0.01 was construed as significant; NS denotes P > 0.01.
The relationships among TG, AVF, SHBG, and IL-6 are depicted graphically in Fig. 2 in a triptych. HDL-C as the dependent variable correlated negatively with each of insulin, AVF, TAF, SCF, and IL-6 (10 −4 < P ≤ 0.0060). By multivariate assessment, HDL-C correlated conjointly with age (positively), AVF and IL-6 (negatively) (overall R 2 = 0.281, P = 2.3 × 10
−8
). The relationships among HDL, AVF, and IL-6 are presented graphically in Fig. 3 .
NonHDL-C provides an indirect estimate of all apoBcarried cholesterol across the female adult life. NonHDL-C in all 120 women was related strongly and positively to each of BMI, AVF, TAF, and SCF at univariate P 0.0001 < P ≤ 0.0004. Age was a NS trend for nonHDL-C at P = 0.0123. After multivariate adjustment, nonHDL-C correlated best with TAF and IL-8 both positively at overall multivariate R 2 = 0.169 and P = 2.0 × 10
. The joint correlations of nonHDL-C (dependent variables) with IL-8 and TAF are depicted in Fig. 4 .
LDL-C was correlated with the independent variables, TAF and SCF, both positively (P < 0.0005). By multivariate analysis, IL-8 and especially TAF had strong associations with LDL-C at a multivariate adjusted R 2 = 0.094 and P = 0.0031.
Using an indirect estimate of insulin resistance, the insulin/ glucose ratio, correlation analyses reveled that both TG (positively) and HDL-C (negatively) correlated strongly with this ratio (both P < 0.00001). Further, the insulin/glucose ratio correlated univariately with BMI (P < 0.00001), IL-8 (P < 0.00001). By multivariate regression, the insulin/glucose ratio was highly significantly explained jointly at P = 5.8 × 10 −17 and R 2 = 0.498. Homeostatic model assessment index proved similar (P < 0.001) relationships, which would be consistent with significant interactions among body composition, glucose, inflammation, and in lesser measure free T.
Univariate and stepwise forward-selection multivariate linear regressions were also performed separately after segmenting the patients by pre-(N = 60) and post-(N = 60) menopausal status. The resulting outcomes at P < 0.01 are given in Table 4 . Boldface values denote multivariate outcomes and regular type plus boldface univariate Boldface denotes significant at multicomparison P < 0.01
Data are from N = 120 women SCF subcutaneous fat, TAF total abdominal fat, AVF abdominal visceral fat, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, nonHDL-C non-high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol 
Discussion
The present analyses in healthy women across five decades of age have elucidated associations among the dependent variables TC, nonHDL-C, HDL-C, TG, and LDL and the independent variables age, selected cytokines and abdominal subcutaneous, total and visceral fat. This was a pilot study, not a multicentered analysis, comprising healthy women without comorbidities or hypolipidemic interventions. The goal was to correlate the five standard lipid measures with age, important cytokines, sex steroids, and abdominal fat depots without confounding by disease. Under these conditions, for the entire lifetime group of 120 women, only TC rose significantly with age. NonHDL-C and LDL-C correlated with both TAF and IL-8. On the other hand, TG and HDL-C correlated with both AVF and IL-6. To our knowledge, these results are the first to correlate nonHDL-C and LDL-C negatively to both TAF and IL-8, and to correlate TG and HDL-C positively to both AVF and IL-8. We also confirm strongly positive associations of AVF with TG in women across the full adult lifespan. In contrast, most earlier studies assessed AVF indirectly by way of waist circumference and/or BMI, rather than CT scan, and evaluated only pre-or postmenopausal individuals [20, 21] .
The largest R 2 observed here in all 120 women was 0.389 for TG's correlation with SHBG, AVF, and IL-6 jointly. Explaining nearly 40 % of the variance in TG is numerically impressive, since earlier reports suggested that lipoprotein-body fat correlations are relatively weak in women compared with men [2, 22] , and depend on race and pathophysiology [8] [9] [10] [11] 23] . Associations of SHBG, AVF, and IL-6 with TG may reflect in part the fact that AVF accumulation correlates both with insulin resistance, and hence low SHBG, and with inflammatory markers like IL-6 [24, 25] . Additionally, the insulin/glucose ratio was univariately associated with each of BMI (P < 0.00001), IL-8 (P < 0.00001), and free T (P = 0.00031). These three individual correlates of insulin/glucose ratios were highly significant as joint correlates P = 5.8 × 10 −17 and R 2 = 0.498. The relationships suggest significant interactions among body composition, glucose, systemic inflammation markers, and in lesser measure free T.
Viewed from the perspective of adipose depots, AVF strongly correlated with TG and nonHDL-C concentrations, possibly on the grounds that AVF associates with insulin resistance [2, 26, 27] . On the other hand, SCF was the fat compartment most correlated with HDL-C and LDL concentrations. The exact bases for these correlations with SCF are not so evident. Indeed, HDL and LDL-regulating factors like GH and IGF-I tend to reflect AVF more than SCF [28] .
A salient outcome was the lack of significant relationships between any of the five lipid moieties and the five sex-steroid fractions estimated here by mass spectrometry (estradiol, estrone, TT, free T, bioavailable T). Several prior studies have correlated indirect indices of androgen availability with atherogenic lipids [26, [29] [30] [31] [32] , but others have not [33] . Our data are important because they are the first mass spectrometry estimates of sex steroids in this context in women. In principle, the present criterion-based method of gonadal steroid quantification should be more specific to the question whether sex hormones determine lipid concentrations in healthy women over their lifetime.
Inflammatory markers, like TNF-alpha and possibly interferon-gamma, have been associated with TG, age, BMI, and LDL/HDL in other studies [4, 34, 35] . Here, we could demonstrate multivariate-adjusted correlations between IL-6 and TG (P = 0.0016) as well as between IL-6 and HDL-C (P = 0.0063). On the other hand, IL-8 was numerically correlated with nonHDL-C and LDL-C in multivariate analysis. The exact mechanisms of IL-6 and Il-8's correlations with lipids are not known. However, CT-based estimates of fat depots correlated with interleukin levels, viz., here AVF correlated positively with Il-6, whereas TAF correlated positively with IL-8. In this regard, two recent papers are of interest, one showing that lp(a)-albeit not measured here-may induce IL-8, suggesting a reverse linkage between inflammation and lipid moieties [36] . Analogously, another study reported that LDL per se can induce IL-8 expression. Accordingly, the causal direction may not necessarily be IL → lipid, but also lipid → IL [37] . Thus, abdominal fat depots may underlie some of the cytokine-lipid correlations. Other investigations have correlated immunoreactive SHBG inversely with TG [38, 39] , HDL-C [1, 38] , LDL-C [29, 39] , hsCRP [32] , and nonHDL-C [33] .
When statistical analyses were segmented to evaluate pre-and postmenopausal women (60 in each group) separately, several novel correlations emerged (Results). In premenopausal women only, TC correlated positively with age; HDL correlated negatively with IL-6; and both nonHDL and LDL correlated positively with TAF. Conversely, in postmenopausal women only, TG were associated with each of SHBG (negatively), AVF (positively), IL-8 (positively), and adiponectin (negatively). These examples illustrate the possibility of more complex distinctions by menopausal status. However, the demonstration of strong statistical correlations does not per se establish causality or imply any direction of causality. Nonetheless, the novel exploratory outcomes should provide useful bases for hypothesis generation in the arena of lipid determinants in healthy unmedicated women.
Caveats include the consideration that abdominal fat compartments exhibit cross-correlations among themselves, and that not all fat compartments were measured here (e.g., liver and muscle). Other factors may also determine lipid levels in women who have either a broader range of BMI or are not healthy. Aging itself increases comorbidities. Our data were restricted to healthy individuals. For example, in the presence of systemic disease, HDL-C or TC levels may fall with age. Other correlates of disease not assessed here could include age-related decreases in physical fitness [40] , increased hepatic and intramyocellular lipids as markers of insulin resistance [27] , genetic variations in adipocyte 11-beta hydroxysteroid dehydrogenase types I and II [2, 20] , sedentarism or exercise [21, 41] , overall weight loss [5, 6] , reduced lean body mass [42] , and changes in indirect measures of body composition like normal-weight obesity, waist circumference, and waist:hip ratio [21, 40, 42] . In addition to selecting healthy women ages 21-79 years, our investigations are limited by inclusion of primarily (93 %) Caucasian volunteers from Olmsted County, Minnesota, USA. Lastly, much larger cohorts of both pre-and postmenopausal individuals, ultimately evaluated in longitudinal studies, will be required to relate the present data to ASCVD outcomes per se, and to evaluate possible causal linkages. Indeed, correlations neither prove causality nor establish a direction for causality, rather offering hypotheses for further longitudinal, interventional, and genetic investigations.
In summary, the present outcomes introduce a framework in which age, interleukins, and CT-estimated fat compartments correlate with certain lipid concentrations in healthy women with a wide range of BMI's and ages over full adult female lifetime. In particular, both TG and HDL-C correlate with IL-6 and AVF, whereas both nonHDL-C and LDL-C associate with IL-8 and TAF. By the criterion method of mass spectrometry, the sex steroids evaluated here did not significantly associate with lipid moieties across the female age range of 21-79 years. This was also true in pre-and postmenopausal subgroups. Longitudinal studies will be ultimately required to test causal linkages.
